Concepedia

LB0005 ORELABRUTINIB, AN IRREVERSIBLE INHIBITOR OF BRUTON'S TYROSINE KINASE (BTK), FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE IB/IIA DOSE-FINDING STUDY

R. Li, X. Zhu, S. Liu, X. Zhang, C. Xie, Z. Fu, Anaoxue Huang, L. Sun, D. Liu, Jingrun Zhao,

Annals of the Rheumatic Diseases · 2022 · 12 citations · 0 references

DOIFull text

Open access

Concepts